Global Needle-Free Drug Injection Systems Market to Reach $29.9 Billion by 2030
NEW YORK, March 10, 2023 /PRNewswire/ -- The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China's already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.
Read the full report: https://www.reportlinker.com/p04910454/?utm_source=PRN
Global Needle-Free Drug Injection Systems Market to Reach $29.9 Billion by 2030
In the changed post COVID-19 business landscape, the global market for Needle-Free Drug Injection Systems estimated at US$12.6 Billion in the year 2022, is projected to reach a revised size of US$29.9 Billion by 2030, growing at aCAGR of 11.4% over the period 2022-2030. Jet Injectors, one of the segments analyzed in the report, is projected to record 11.5% CAGR and reach US$9.5 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Novel Needle-Free segment is readjusted to a revised 10.1% CAGR for the next 8-year period.
The U.S. Market is Estimated at $3.4 Billion, While China is Forecast to Grow at 15.6% CAGR
The Needle-Free Drug Injection Systems market in the U.S. is estimated at US$3.4 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$6.7 Billion by the year 2030 trailing a CAGR of 15.6% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.7% and 9.1% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 8.1% CAGR.
Select Competitors (Total 52 Featured)
- AKRA Dermojet
- Crossject SA
- D`Antonio Consultants International, Inc.
- Medical International Technologies, Inc.
- National Medical Products, Inc.
- PharmaJet
- Zogenix, Inc.
Read the full report: https://www.reportlinker.com/p04910454/?utm_source=PRN
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Needle-Free Drug Injection Systems: An Overview
Recent Market Activity
Needle-Free Drug Delivery Systems: An Overview
Brief Glance of Needle-Free Drug Delivery Systems
Advantages
Disadvantages
Needle-Free Drug Injection System: Market Dynamics
Drivers and Barriers of Needle-free Drug Injection Systems Market
Increasing Geriatric Population to Drive Market
Improving Healthcare Expenditure to Foster Growth
Increasing Incidence of Cancer Bodes Well for Needle-free Drug
Injection Systems
Global Cancer Prevalence Statistics - Opportunity Indicators
Expanding Therapeutic Applications to Generate Growth
Opportunities
Competitive Scenario
Needle-free Jet Injections: Future Burning Bright
Growth Factors
Next Generation Needle-free Jet Technologies
Advantageous to Different Stakeholders
Applications
Formulation Challenges
Current Development Status
The Road Ahead
Innovations in Needle-Free Drug Injection System Technology
Needle-free Arterial Non-Injectable Connector
Pulsed Micro Jets
Needle-Free Drug Injection Systems - Global Key Competitors
Percentage Market Share in 2022 (E)
Impact of Covid-19 and a Looming Global Recession
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
2. FOCUS ON SELECT PLAYERS
AKRA Dermojet (France)
Crossject SA (France)
D?Antonio Consultants International, Inc. (USA)
Medical International Technologies, Inc. (Canada)
National Medical Products, Inc. (USA)
PharmaJet (USA)
Zogenix, Inc. (USA)
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for
Insulin Delivery by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR
Table 2: World Historic Review for Insulin Delivery by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 3: World 16-Year Perspective for Insulin Delivery by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 4: World Recent Past, Current & Future Analysis for Pain
Management by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR
Table 5: World Historic Review for Pain Management by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 6: World 16-Year Perspective for Pain Management by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 7: World Recent Past, Current & Future Analysis for
Vaccine Delivery by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR
Table 8: World Historic Review for Vaccine Delivery by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 9: World 16-Year Perspective for Vaccine Delivery by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 10: World Recent Past, Current & Future Analysis for
Pediatric Injections by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR
Table 11: World Historic Review for Pediatric Injections by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 12: World 16-Year Perspective for Pediatric Injections by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 13: World Recent Past, Current & Future Analysis for
Other Applications by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR
Table 14: World Historic Review for Other Applications by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 15: World 16-Year Perspective for Other Applications by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 16: World Recent Past, Current & Future Analysis for
Needle-Free Drug Injection Systems by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Million for Years 2022 through 2030 and % CAGR
Table 17: World Historic Review for Needle-Free Drug Injection
Systems by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 18: World 16-Year Perspective for Needle-Free Drug
Injection Systems by Geographic Region - Percentage Breakdown
of Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets for
Years 2014, 2023 & 2030
Table 19: World Recent Past, Current & Future Analysis for Jet
Injectors by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR
Table 20: World Historic Review for Jet Injectors by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR
Table 21: World 16-Year Perspective for Jet Injectors by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 22: World Recent Past, Current & Future Analysis for
Novel Needle-Free by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR
Table 23: World Historic Review for Novel Needle-Free by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 24: World 16-Year Perspective for Novel Needle-Free by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 25: World Recent Past, Current & Future Analysis for
Inhaler by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR
Table 26: World Historic Review for Inhaler by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR
Table 27: World 16-Year Perspective for Inhaler by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2014, 2023 & 2030
Table 28: World Recent Past, Current & Future Analysis for
Transdermal Patch by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Million for Years 2022 through 2030 and % CAGR
Table 29: World Historic Review for Transdermal Patch by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 30: World 16-Year Perspective for Transdermal Patch by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2014, 2023 & 2030
Table 31: World Needle-Free Drug Injection Systems Market
Analysis of Annual Sales in US$ Million for Years 2014 through
2030
III. MARKET ANALYSIS
UNITED STATES
Needle-Free Drug Injection Systems Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in the United States
for 2023 (E)
Table 32: USA Recent Past, Current & Future Analysis for
Needle-Free Drug Injection Systems by Application - Insulin
Delivery, Pain Management, Vaccine Delivery, Pediatric
Injections and Other Applications - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR
Table 33: USA Historic Review for Needle-Free Drug Injection
Systems by Application - Insulin Delivery, Pain Management,
Vaccine Delivery, Pediatric Injections and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 34: USA 16-Year Perspective for Needle-Free Drug
Injection Systems by Application - Percentage Breakdown of
Value Sales for Insulin Delivery, Pain Management, Vaccine
Delivery, Pediatric Injections and Other Applications for the
Years 2014, 2023 & 2030
Table 35: USA Recent Past, Current & Future Analysis for
Needle-Free Drug Injection Systems by Technology - Jet
Injectors, Novel Needle-Free, Inhaler and Transdermal Patch -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 36: USA Historic Review for Needle-Free Drug Injection
Systems by Technology - Jet Injectors, Novel Needle-Free,
Inhaler and Transdermal Patch Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR
Table 37: USA 16-Year Perspective for Needle-Free Drug
Injection Systems by Technology - Percentage Breakdown of Value
Sales for Jet Injectors, Novel Needle-Free, Inhaler and
Transdermal Patch for the Years 2014, 2023 & 2030
CANADA
Table 38: Canada Recent Past, Current & Future Analysis for
Needle-Free Drug Injection Systems by Application - Insulin
Delivery, Pain Management, Vaccine Delivery, Pediatric
Injections and Other Applications - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR
Table 39: Canada Historic Review for Needle-Free Drug Injection
Systems by Application - Insulin Delivery, Pain Management,
Vaccine Delivery, Pediatric Injections and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 40: Canada 16-Year Perspective for Needle-Free Drug
Injection Systems by Application - Percentage Breakdown of
Value Sales for Insulin Delivery, Pain Management, Vaccine
Delivery, Pediatric Injections and Other Applications for the
Years 2014, 2023 & 2030
Table 41: Canada Recent Past, Current & Future Analysis for
Needle-Free Drug Injection Systems by Technology - Jet
Injectors, Novel Needle-Free, Inhaler and Transdermal Patch -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 42: Canada Historic Review for Needle-Free Drug Injection
Systems by Technology - Jet Injectors, Novel Needle-Free,
Inhaler and Transdermal Patch Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR
Table 43: Canada 16-Year Perspective for Needle-Free Drug
Injection Systems by Technology - Percentage Breakdown of Value
Sales for Jet Injectors, Novel Needle-Free, Inhaler and
Transdermal Patch for the Years 2014, 2023 & 2030
JAPAN
Needle-Free Drug Injection Systems Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
Table 44: Japan Recent Past, Current & Future Analysis for
Needle-Free Drug Injection Systems by Application - Insulin
Delivery, Pain Management, Vaccine Delivery, Pediatric
Injections and Other Applications - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR
Table 45: Japan Historic Review for Needle-Free Drug Injection
Systems by Application - Insulin Delivery, Pain Management,
Vaccine Delivery, Pediatric Injections and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 46: Japan 16-Year Perspective for Needle-Free Drug
Injection Systems by Application - Percentage Breakdown of
Value Sales for Insulin Delivery, Pain Management, Vaccine
Delivery, Pediatric Injections and Other Applications for the
Years 2014, 2023 & 2030
Table 47: Japan Recent Past, Current & Future Analysis for
Needle-Free Drug Injection Systems by Technology - Jet
Injectors, Novel Needle-Free, Inhaler and Transdermal Patch -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 48: Japan Historic Review for Needle-Free Drug Injection
Systems by Technology - Jet Injectors, Novel Needle-Free,
Inhaler and Transdermal Patch Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR
Table 49: Japan 16-Year Perspective for Needle-Free Drug
Injection Systems by Technology - Percentage Breakdown of Value
Sales for Jet Injectors, Novel Needle-Free, Inhaler and
Transdermal Patch for the Years 2014, 2023 & 2030
CHINA
Needle-Free Drug Injection Systems Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in China for 2023 (E)
Table 50: China Recent Past, Current & Future Analysis for
Needle-Free Drug Injection Systems by Application - Insulin
Delivery, Pain Management, Vaccine Delivery, Pediatric
Injections and Other Applications - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR
Table 51: China Historic Review for Needle-Free Drug Injection
Systems by Application - Insulin Delivery, Pain Management,
Vaccine Delivery, Pediatric Injections and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 52: China 16-Year Perspective for Needle-Free Drug
Injection Systems by Application - Percentage Breakdown of
Value Sales for Insulin Delivery, Pain Management, Vaccine
Delivery, Pediatric Injections and Other Applications for the
Years 2014, 2023 & 2030
Table 53: China Recent Past, Current & Future Analysis for
Needle-Free Drug Injection Systems by Technology - Jet
Injectors, Novel Needle-Free, Inhaler and Transdermal Patch -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 54: China Historic Review for Needle-Free Drug Injection
Systems by Technology - Jet Injectors, Novel Needle-Free,
Inhaler and Transdermal Patch Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR
Table 55: China 16-Year Perspective for Needle-Free Drug
Injection Systems by Technology - Percentage Breakdown of Value
Sales for Jet Injectors, Novel Needle-Free, Inhaler and
Transdermal Patch for the Years 2014, 2023 & 2030
EUROPE
Needle-Free Drug Injection Systems Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
Table 56: Europe Recent Past, Current & Future Analysis for
Needle-Free Drug Injection Systems by Application - Insulin
Delivery, Pain Management, Vaccine Delivery, Pediatric
Injections and Other Applications - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR
Table 57: Europe Historic Review for Needle-Free Drug Injection
Systems by Application - Insulin Delivery, Pain Management,
Vaccine Delivery, Pediatric Injections and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 58: Europe 16-Year Perspective for Needle-Free Drug
Injection Systems by Application - Percentage Breakdown of
Value Sales for Insulin Delivery, Pain Management, Vaccine
Delivery, Pediatric Injections and Other Applications for the
Years 2014, 2023 & 2030
Table 59: Europe Recent Past, Current & Future Analysis for
Needle-Free Drug Injection Systems by Geographic Region -
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2022 through 2030 and % CAGR
Table 60: Europe Historic Review for Needle-Free Drug Injection
Systems by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Million for Years 2014 through 2021 and
% CAGR
Table 61: Europe 16-Year Perspective for Needle-Free Drug
Injection Systems by Geographic Region - Percentage Breakdown
of Value Sales for France, Germany, Italy, UK, Spain, Russia
and Rest of Europe Markets for Years 2014, 2023 & 2030
Table 62: Europe Recent Past, Current & Future Analysis for
Needle-Free Drug Injection Systems by Technology - Jet
Injectors, Novel Needle-Free, Inhaler and Transdermal Patch -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 63: Europe Historic Review for Needle-Free Drug Injection
Systems by Technology - Jet Injectors, Novel Needle-Free,
Inhaler and Transdermal Patch Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR
Table 64: Europe 16-Year Perspective for Needle-Free Drug
Injection Systems by Technology - Percentage Breakdown of Value
Sales for Jet Injectors, Novel Needle-Free, Inhaler and
Transdermal Patch for the Years 2014, 2023 & 2030
FRANCE
Needle-Free Drug Injection Systems Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in France for 2023 (E)
Table 65: France Recent Past, Current & Future Analysis for
Needle-Free Drug Injection Systems by Application - Insulin
Delivery, Pain Management, Vaccine Delivery, Pediatric
Injections and Other Applications - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR
Table 66: France Historic Review for Needle-Free Drug Injection
Systems by Application - Insulin Delivery, Pain Management,
Vaccine Delivery, Pediatric Injections and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 67: France 16-Year Perspective for Needle-Free Drug
Injection Systems by Application - Percentage Breakdown of
Value Sales for Insulin Delivery, Pain Management, Vaccine
Delivery, Pediatric Injections and Other Applications for the
Years 2014, 2023 & 2030
Table 68: France Recent Past, Current & Future Analysis for
Needle-Free Drug Injection Systems by Technology - Jet
Injectors, Novel Needle-Free, Inhaler and Transdermal Patch -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 69: France Historic Review for Needle-Free Drug Injection
Systems by Technology - Jet Injectors, Novel Needle-Free,
Inhaler and Transdermal Patch Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR
Table 70: France 16-Year Perspective for Needle-Free Drug
Injection Systems by Technology - Percentage Breakdown of Value
Sales for Jet Injectors, Novel Needle-Free, Inhaler and
Transdermal Patch for the Years 2014, 2023 & 2030
GERMANY
Needle-Free Drug Injection Systems Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Germany for 2023 (E)
Table 71: Germany Recent Past, Current & Future Analysis for
Needle-Free Drug Injection Systems by Application - Insulin
Delivery, Pain Management, Vaccine Delivery, Pediatric
Injections and Other Applications - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR
Table 72: Germany Historic Review for Needle-Free Drug
Injection Systems by Application - Insulin Delivery, Pain
Management, Vaccine Delivery, Pediatric Injections and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR
Table 73: Germany 16-Year Perspective for Needle-Free Drug
Injection Systems by Application - Percentage Breakdown of
Value Sales for Insulin Delivery, Pain Management, Vaccine
Delivery, Pediatric Injections and Other Applications for the
Years 2014, 2023 & 2030
Table 74: Germany Recent Past, Current & Future Analysis for
Needle-Free Drug Injection Systems by Technology - Jet
Injectors, Novel Needle-Free, Inhaler and Transdermal Patch -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 75: Germany Historic Review for Needle-Free Drug
Injection Systems by Technology - Jet Injectors, Novel
Needle-Free, Inhaler and Transdermal Patch Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 76: Germany 16-Year Perspective for Needle-Free Drug
Injection Systems by Technology - Percentage Breakdown of Value
Sales for Jet Injectors, Novel Needle-Free, Inhaler and
Transdermal Patch for the Years 2014, 2023 & 2030
ITALY
Table 77: Italy Recent Past, Current & Future Analysis for
Needle-Free Drug Injection Systems by Application - Insulin
Delivery, Pain Management, Vaccine Delivery, Pediatric
Injections and Other Applications - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR
Table 78: Italy Historic Review for Needle-Free Drug Injection
Systems by Application - Insulin Delivery, Pain Management,
Vaccine Delivery, Pediatric Injections and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 79: Italy 16-Year Perspective for Needle-Free Drug
Injection Systems by Application - Percentage Breakdown of
Value Sales for Insulin Delivery, Pain Management, Vaccine
Delivery, Pediatric Injections and Other Applications for the
Years 2014, 2023 & 2030
Table 80: Italy Recent Past, Current & Future Analysis for
Needle-Free Drug Injection Systems by Technology - Jet
Injectors, Novel Needle-Free, Inhaler and Transdermal Patch -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 81: Italy Historic Review for Needle-Free Drug Injection
Systems by Technology - Jet Injectors, Novel Needle-Free,
Inhaler and Transdermal Patch Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR
Table 82: Italy 16-Year Perspective for Needle-Free Drug
Injection Systems by Technology - Percentage Breakdown of Value
Sales for Jet Injectors, Novel Needle-Free, Inhaler and
Transdermal Patch for the Years 2014, 2023 & 2030
UNITED KINGDOM
Needle-Free Drug Injection Systems Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in the United Kingdom
for 2023 (E)
Table 83: UK Recent Past, Current & Future Analysis for
Needle-Free Drug Injection Systems by Application - Insulin
Delivery, Pain Management, Vaccine Delivery, Pediatric
Injections and Other Applications - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR
Table 84: UK Historic Review for Needle-Free Drug Injection
Systems by Application - Insulin Delivery, Pain Management,
Vaccine Delivery, Pediatric Injections and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 85: UK 16-Year Perspective for Needle-Free Drug Injection
Systems by Application - Percentage Breakdown of Value Sales
for Insulin Delivery, Pain Management, Vaccine Delivery,
Pediatric Injections and Other Applications for the Years 2014,
2023 & 2030
Table 86: UK Recent Past, Current & Future Analysis for
Needle-Free Drug Injection Systems by Technology - Jet
Injectors, Novel Needle-Free, Inhaler and Transdermal Patch -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 87: UK Historic Review for Needle-Free Drug Injection
Systems by Technology - Jet Injectors, Novel Needle-Free,
Inhaler and Transdermal Patch Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR
Table 88: UK 16-Year Perspective for Needle-Free Drug Injection
Systems by Technology - Percentage Breakdown of Value Sales for
Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch
for the Years 2014, 2023 & 2030
SPAIN
Table 89: Spain Recent Past, Current & Future Analysis for
Needle-Free Drug Injection Systems by Application - Insulin
Delivery, Pain Management, Vaccine Delivery, Pediatric
Injections and Other Applications - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR
Table 90: Spain Historic Review for Needle-Free Drug Injection
Systems by Application - Insulin Delivery, Pain Management,
Vaccine Delivery, Pediatric Injections and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 91: Spain 16-Year Perspective for Needle-Free Drug
Injection Systems by Application - Percentage Breakdown of
Value Sales for Insulin Delivery, Pain Management, Vaccine
Delivery, Pediatric Injections and Other Applications for the
Years 2014, 2023 & 2030
Table 92: Spain Recent Past, Current & Future Analysis for
Needle-Free Drug Injection Systems by Technology - Jet
Injectors, Novel Needle-Free, Inhaler and Transdermal Patch -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 93: Spain Historic Review for Needle-Free Drug Injection
Systems by Technology - Jet Injectors, Novel Needle-Free,
Inhaler and Transdermal Patch Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR
Table 94: Spain 16-Year Perspective for Needle-Free Drug
Injection Systems by Technology - Percentage Breakdown of Value
Sales for Jet Injectors, Novel Needle-Free, Inhaler and
Transdermal Patch for the Years 2014, 2023 & 2030
RUSSIA
Table 95: Russia Recent Past, Current & Future Analysis for
Needle-Free Drug Injection Systems by Application - Insulin
Delivery, Pain Management, Vaccine Delivery, Pediatric
Injections and Other Applications - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR
Table 96: Russia Historic Review for Needle-Free Drug Injection
Systems by Application - Insulin Delivery, Pain Management,
Vaccine Delivery, Pediatric Injections and Other Applications
Markets - Independent Analysis of Annual Sales in US$ Million
for Years 2014 through 2021 and % CAGR
Table 97: Russia 16-Year Perspective for Needle-Free Drug
Injection Systems by Application - Percentage Breakdown of
Value Sales for Insulin Delivery, Pain Management, Vaccine
Delivery, Pediatric Injections and Other Applications for the
Years 2014, 2023 & 2030
Table 98: Russia Recent Past, Current & Future Analysis for
Needle-Free Drug Injection Systems by Technology - Jet
Injectors, Novel Needle-Free, Inhaler and Transdermal Patch -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 99: Russia Historic Review for Needle-Free Drug Injection
Systems by Technology - Jet Injectors, Novel Needle-Free,
Inhaler and Transdermal Patch Markets - Independent Analysis of
Annual Sales in US$ Million for Years 2014 through 2021 and %
CAGR
Table 100: Russia 16-Year Perspective for Needle-Free Drug
Injection Systems by Technology - Percentage Breakdown of Value
Sales for Jet Injectors, Novel Needle-Free, Inhaler and
Transdermal Patch for the Years 2014, 2023 & 2030
REST OF EUROPE
Table 101: Rest of Europe Recent Past, Current & Future
Analysis for Needle-Free Drug Injection Systems by Application -
Insulin Delivery, Pain Management, Vaccine Delivery,
Pediatric Injections and Other Applications - Independent
Analysis of Annual Sales in US$ Million for the Years 2022
through 2030 and % CAGR
Table 102: Rest of Europe Historic Review for Needle-Free Drug
Injection Systems by Application - Insulin Delivery, Pain
Management, Vaccine Delivery, Pediatric Injections and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR
Table 103: Rest of Europe 16-Year Perspective for Needle-Free
Drug Injection Systems by Application - Percentage Breakdown of
Value Sales for Insulin Delivery, Pain Management, Vaccine
Delivery, Pediatric Injections and Other Applications for the
Years 2014, 2023 & 2030
Table 104: Rest of Europe Recent Past, Current & Future
Analysis for Needle-Free Drug Injection Systems by Technology -
Jet Injectors, Novel Needle-Free, Inhaler and Transdermal Patch -
Independent Analysis of Annual Sales in US$ Million for the
Years 2022 through 2030 and % CAGR
Table 105: Rest of Europe Historic Review for Needle-Free Drug
Injection Systems by Technology - Jet Injectors, Novel
Needle-Free, Inhaler and Transdermal Patch Markets -
Independent Analysis of Annual Sales in US$ Million for Years
2014 through 2021 and % CAGR
Table 106: Rest of Europe 16-Year Perspective for Needle-Free
Drug Injection Systems by Technology - Percentage Breakdown of
Value Sales for Jet Injectors, Novel Needle-Free, Inhaler and
Transdermal Patch for the Years 2014, 2023 & 2030
ASIA-PACIFIC
Needle-Free Drug Injection Systems Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Asia-Pacific for
2023 (E)
Table 107: Asia-Pacific Recent Past, Current & Future Analysis
for Needle-Free Drug Injection Systems by Application - Insulin
Delivery, Pain Management, Vaccine Delivery, Pediatric
Injections and Other Applications - Independent Analysis of
Annual Sales in US$ Million for the Years 2022 through 2030 and
% CAGR
Table 108: Asia-Pacific Historic Review for Needle-Free Drug
Injection Systems by Application - Insulin Delivery, Pain
Management, Vaccine Delivery, Pediatric Injections and Other
Applications Markets - Independent Analysis of Annual Sales in
US$ Million for Years 2014 through 2021 and % CAGR
Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p04910454/?utm_source=PRN
About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.
Contact Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001
SOURCE Reportlinker
Share this article